Update on the Management of Gastroenteropancreatic Neuroendocrine Tumors With Emphasis on the Role of Imaging

被引：32
|
作者：
Kim, Kyung Won [1 ,2 ,3 ]
Krajewski, Katherine M. [1 ]
Nishino, Mizuki [1 ]
Jagannathan, Jyothi P. [1 ]
Shinagare, Atul B. [1 ]
Tirumani, Sree Harsha [1 ]
Ramaiya, Nikhil H. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2013年 / 201卷 / 04期
基金：
美国国家卫生研究院;
关键词：
gastroenteropancreatic neuroendocrine tumor; guidelines; molecular targeted therapy; CLINICAL-PRACTICE GUIDELINES; CARCINOID-TUMORS; SOMATOSTATIN; METASTASIS; NEOPLASMS; DIAGNOSIS; ERA;
D O I：
10.2214/AJR.12.10240
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. The purposes of this article are to review the current management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) based on the 2012 National Comprehensive Cancer Network guidelines and to describe the role of imaging in a multidisciplinary approach. CONCLUSION. The management of GEP-NETs has become complex, requiring a multidisciplinary approach. The World Health Organization classification of GEP-NETs has been revised; the U.S. Food and Drug Administration has approved molecular targeted agents (sunitinib, everolimus) for the treatment of pancreatic NETs; and the National Comprehensive Cancer Network clinical practice guidelines have been updated.
引用
收藏
页码：811 / 824
页数：14
相关论文
共 50 条
  • [1] Update in the management of gastroenteropancreatic neuroendocrine tumors
    Sedlack, Andrew J. H.
    Varghese, Diana Grace
    Naimian, Amirkia
    Anari, Pouria Yazdian
    Bodei, Lisa
    Hallet, Julie
    Riechelmann, Rachel P.
    Halfdanarson, Thor
    Capdevilla, Jaume
    Del Rivero, Jaydira
    CANCER, 2024, 130 (18) : 3090 - 3105
  • [2] Gastroenteropancreatic Neuroendocrine Tumors: Role of Imaging in Diagnosis and Management
    Sahani, Dushyant V.
    Bonaffini, Pietro A.
    Fernandez-Del Castillo, Carlos
    Blake, Michael A.
    RADIOLOGY, 2013, 266 (01) : 38 - 61
  • [3] An update on the diagnosis and management of gastroenteropancreatic neuroendocrine tumors
    Ito, Tetsuhide
    ANNALS OF ONCOLOGY, 2018, 29 : 42 - 42
  • [4] Update on gastroenteropancreatic neuroendocrine tumors
    Andreasi, Valentina
    Partelli, Stefano
    Muffatti, Francesca
    Manzoni, Marco F.
    Capurso, Gabriele
    Falconi, Massimo
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (02) : 171 - 182
  • [5] An Update on Gastroenteropancreatic Neuroendocrine Tumors
    Cives, Mauro
    Strosberg, Jonathan
    ONCOLOGY-NEW YORK, 2014, 28 (09): : 749 - 758
  • [6] Endoscopic imaging in the management of gastroenteropancreatic neuroendocrine tumors
    Pellicano, Rinaldo
    Fagoonee, Sharmila
    Altruda, Fiorella
    Bruno, Mauro
    Saracco, Giorgio M.
    De Angelis, Claudio
    MINERVA ENDOCRINOLOGICA, 2016, 41 (04) : 490 - 498
  • [7] Gastroenteropancreatic Neuroendocrine Tumors: Update on Therapeutics
    Ganetsky, Alex
    Bhatt, Valkal
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (06) : 851 - 862
  • [8] Imaging of gastroenteropancreatic neuroendocrine tumors
    Tan, Eik Hock
    Tan, Cher Heng
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2011, 2 (01): : 28 - 43
  • [9] The management of neuroendocrine gastroenteropancreatic tumors
    Berrad, S.
    Erraichi, H.
    Nouikh, L.
    Messoudi, K.
    Oualla, K.
    Benbrahim, Z.
    Arifi, S.
    Mellas, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] Update on the Role of Somatostatin Analogs for the Treatment of Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Toumpanakis, Christos
    Caplin, Martyn E.
    SEMINARS IN ONCOLOGY, 2013, 40 (01) : 56 - 68
12345